As researchers look for new approaches for tough-to-treat cancer, many are looking into genetics – more specifically, they’re looking at the type of genetic mutations found in cancerous tumors. One company in particular, called Loxo Oncology is building drugs that act on those mutations, so that the type of cancer someone has wouldn’t matter so much as the genetic information gleaned from sequencing the tumor.